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ABSTRACT 
Metabolic syndrome (MS) is a condition associated with metabolic abnormalities that are characterized by cen-
tral obesity (e.g. waist circumference or body mass index), hypertension (e.g. systolic or diastolic blood pres-
sure), hyperglycemia (e.g. fasting plasma glucose) and dyslipidemia (e.g. triglyceride and high-density lipopro-
tein cholesterol). It is also associated with the development of diabetes mellitus (DM) type 2 and cardiovascular 
disease (CVD). Therefore, the rapid identification of MS is required to prevent the occurrence of such diseases. 
Herein, we review the utilization of data mining approaches for MS identification. Furthermore, the concept of 
quantitative population-health relationship (QPHR) is also presented, which can be defined as the elucida-
tion/understanding of the relationship that exists between health parameters and health status. The QPHR model-
ing uses data mining techniques such as artificial neural network (ANN), support vector machine (SVM), princi-
pal component analysis (PCA), decision tree (DT), random forest (RF) and association analysis (AA) for model-
ing and construction of predictive models for MS characterization. The DT method has been found to outperform 
other data mining techniques in the identification of MS status. Moreover, the AA technique has proved useful in 
the discovery of in-depth as well as frequently occurring health parameters that can be used for revealing the 
rules of MS development. This review presents the potential benefits on the applications of data mining as a rap-
id identification tool for classifying MS. 
 
Keywords: metabolic syndrome, health parameters, diabetes mellitus, cardiovascular diseases, data mining, 
QPHR 
 
INTRODUCTION 
Over the past century, the advents in sci-
ence and technology have led to significant 
and enormous changes in the development of 
countries, economies, societies and environ-
ment as well as improving quality of life. 
However, the effects of these advancements 
have led to changes and perturbation of indi-
vidual/population life style, environment, 
culture, socioeconomic and community net-
work. As a result, this predisposes the popu-
lation with several internal and external risk 
factors that possibly cause pathological con-
ditions leading up to diseases (Figure 1). 
These diseases occur via multiple risk factors 
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such as being infected by pathogenic micro-
organisms (e.g. bacteria, fungi, parasites and 
viruses), free radicals, carcinogens, toxic 
compounds, pollutants and genetic abnor-
malities. Moreover, lifestyle and dietary 
modifications as well as physical inactivity 
have led to metabolic abnormalities. The 
aforementioned risk factors possibly caused 
diseases such as metabolic syndrome, cardi-
ovascular diseases, diabetes mellitus, cere-
brovascular diseases, foodborne diseases, in-
fectious diseases and cancer. Therefore, fo-
cusing on health parameters provides an in-
teresting opportunity to explore the health 
status in individual and population subjects 
correlating with biochemical changes in the 
body. 
Interestingly, metabolic syndrome (MS) 
has been implicated in the development of 
diabetes mellitus (DM) type 2 (WHO, 2008) 
and cardiovascular disease (CVD) (WHO, 
2007). A MS is defined as a clustering of 
metabolic abnormalities, especially including 
central obesity (e.g. waist circumference 
(WC) or body mass index (BMI)), 
dyslipidemia (e.g. triglyceride (TG) and 
high-density lipoprotein-cholesterol (HDL-
C)), hyperglycemia (e.g. fasting plasma glu-
cose (FPG)), and hypertension (e.g. systolic 
or diastolic blood pressure (SBP or DBP)) 
(Alberti et al., 2009).  
 
 
Figure 1: Risk factors of developing diseases and applications of data mining techniques for as-
sessing health status. AA: association rule analysis, ANN: artificial neural network, DT: decision tree 
analysis, HCA: Hierarchical component analysis, kNN: k-nearest neighbor, MLR: multiple linear re-
gression, PCA: principal component analysis, PLS: partial least square, RF: random forest, SOM: self-
organizing map and SVM: support vector machine 
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The prevalence of DM has been reported 
in global incidences from 150 million in the 
year 2000 with a rapid increase to 220 mil-
lion by 2010 and is estimated to reach 360 
million by 2030 (Amos et al., 1997; WHO, 
2008). Furthermore, the prevalence of CVD 
has been predicted to increase from 17.5 mil-
lion in 2005 to 20 million in 2015 (WHO, 
2007). Therefore, the classification of MS 
for rapid diagnosis to prevent the develop-
ment of type 2 DM and CVD is urgently re-
quired. 
The criteria for identifying MS has been 
developed by many organizations, for exam-
ple, the first criteria was reported by the 
World Health Organization (WHO) in 1999 
(WHO, 1999). Other criteria for defining MS 
have been organized by the European Group 
for the Study of Insulin Resistance (EGIR) 
(Balkau and Charles, 1999), the National 
Cholesterol Education Program Adult 
Treatment Panel III (NCEP ATPIII) (NCEP 
ATPIII, 2001) and the International Diabetes 
Federation (IDF) (Alberti et al., 2009). The 
criteria for identification of MS obtained 
from different organizations are presented in 
Table 1.  
In fact, the geographical location, eth-
nicity, race as well as various social and die-
tary behaviors may lead to obesity, hyperten-
sion and diabetes. Moreover, according to 
the IDF criteria, central obesity (i.e. WC or 
BMI) is usually indicated as the first criteria 
followed by a set of two or more metabolic 
abnormalities. The IDF criteria uses BMI in 
place of waist circumference as it is signifi-
cantly correlated (Ryan et al., 2008). The 
cut-off for obesity as outlined by the WHO is 
BMI ≥30 kg/m2. However, this value was not 
appropriate for identifying the BMI status of 
Asian populations. This may be due to the 
differences in anthropometry, race/ethnic, 
percentage of body fat, society and dietary 
behaviors. Therefore, the cut-off criteria was 
redefined and constructed by the Steering 
Committee of the Regional office for the 
Western Pacific Region of WHO, the Inter-
national Association for the Study of Obesity 
and the International Obesity Taskforce 
(WPRO) to be assigned as the new standard, 
whereby overweight individuals have a BMI 
≥ 23 kg/m2 and obese individuals have a 
BMI ≥ 25 kg/m2 (WHO, 2000). Furthermore, 
Asian populations have a high record of 
morbidity and mortality rate arising from di-
abetes mellitus and cardiovascular disease 
even with a low threshold of central obesity 
with correspondingly lower waist circumfer-
ence and lower BMI. Hence, the BMI cut-off 
for defining obesity in Asian populations 
was changed to 25 kg/m2 (WHO, 2000). This 
new BMI cut-off has demonstrated success-
ful identification of obesity in the Chinese 
(Ko et al., 2001), Japanese (Morimoto et al., 
2008), Korean (Oh et al., 2004), Taiwanese 
(Pan et al., 2004) and Thai (Worachartchee-
wan et al., 2010a) populations as well as be-
ing used as the first criteria for MS identifi-
cation. Furthermore, individuals with an ab-
normal glucose level or a corresponding in-
sulin level as the first component of the 
WHO and EGIR criteria (Table 1), respec-
tively, followed by 2 or more metabolic ab-
normalities were identified as having MS. In 
the NCEP ATPIII criteria, individuals having 
3 or more of the MS components were de-
fined as having MS (Table 1) while the IDF 
criteria considered the use of the central obe-
sity as the first component followed by 2 or 
more abnormalities as identification for MS. 
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Table 1: Criteria for defining metabolic syndrome 
CRITERIA WHO (1999) EGIR (1999) NCEP ATP III 
(2001) 
IDF (2005) 
REQUIREMENT Diabetes, im-
paired fasting 
plasma glu-
cose, glucose 
intolerance or 
insulin re-
sistance plus 
two or more 
of the follow-
ing: 
 
Hyperinsulinaemia 
(fasting insulin 
values above 
quartile for the 
non-diabetic popu-
lation) plus with 
two or more of the 
following: 
Three or more 
of the follow-
ing:  
Central obesity 
(ethic specific 
values, or BMI ≥ 
30 kg/m2) plus 
two or more of 
the following: 
CENTRAL OBESITY BMI > 30 
kg/m2 or 
waist-to-hip 
ratio > 0.90 in 
male or  
> 0.85 in fe-
male 
 
Waist circumfer-
ence ≥ 94 cm in 
male or ≥ 80 cm in 
female 
Waist circum-
ference ≥ 102 
cm in male or ≥ 
88 cm in fe-
male 
 
BLOOD PRESSURE  ≥ 140/90 
mmHg 
≥ 140/90 mmHg)  
or treatment for  
hypertension 
≥ 135/85 
mmHg 
≥ 135/85 mmHg 
or treatment for 
hypertension 
 
TRIGLYCERIDE  ≥ 1.7 mmol/L 
(150 mg/dL) 
≥ 2.0 mmol/L  
(180 mg/dL) or 
treatment for 
dyslipidemia 
 
≥ 1.7 mmol/L 
(150 mg/dL) 
≥ 1.7 mmol/L  
(150 mg/dL) or 
treatment for 
dyslipidemia 
HDL-C < 0.9 mmol/L 
(35 mg/dL) in 
male or  
< 1.0 mmol/L 
(39 mg/dL) in 
female 
< 1.0 mmol/L  
(40 mg/dL) or  
treatment for 
dyslipidemia 
< 1.0 mmol/L 
(40 mg/dL) in 
male or  
< 1.3 mmol/L 
(50 mg/dL) in  
female 
< 1.0 mmol/L  
(40 mg/dL) in 
male or < 1.3 
mmol/L  
(50 mg/dL) in fe-
male or treatment 
for dyslipidemia 
 
FASTING PLASMA 
GLUCOSE 
 ≥ 6.1 mmol/L  
(110 mg/dL) 
≥ 6.1 mmol/L 
(110 mg/dL) 
≥ 5.6 mmol/L  
(100 mg/dL) or 
previously diag-
nosed Type 2 di-
abetes 
 
MICROALBUMINURIA Urinary al-
bumin excre-
tion rate  
≥ 50 g/min 
or albumin: 
creatinine  
ratio  
≥ 30 mg/g 
 
- - - 
BMI: body mass index, EGIR: European Group for the Study of Insulin Resistance, HDL-C: High-
density lipoprotein cholesterol, IDF: International Diabetes Federation, NCEP ATPIII: National Choles-
terol Education Program Adult Treatment Panel III, WHO: World Health Organization 
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OVERVIEW OF DATA MINING FOR 
ASSESSMENT OF HEALTH STATUS 
Concepts of data mining 
Data mining is the process of analyzing 
and managing data from a large pool of in-
formation which leads to the summarization 
of the data for obtaining knowledge and in-
sight into large databases which seek un-
known patterns, classifications, clustering 
and relationships in the data set (Han and 
Kamber, 2001). Data mining is composed of 
six steps according to the Cross-Industry 
Standard Process for Data Mining (CRISP-
DM) established in 1996. The CRISP-DM 
aimed to produce a protocol on the perfor-
mance of data mining that was applicable to 
everyone (from the novice up to an expert in 
the field) for a comprehensive data mining 
methodology and process model (Shearer, 
2000). The Knowledge Discovery in Data-
base (KDD) is also used together with data 
mining. The process of KDD and data mining 
are similar, however, data mining is one of 
the steps of the KDD process which includes 
data selection, data preprocessing, data trans-
formation, data mining, interpreta-
tion/evaluation of the model and use of the 
discovered knowledge (Fayyad et al., 1996). 
A typical data set as formatted in a 
spreadsheet or CSV text file is comprised of 
patients/individuals (rows) as well as health 
parameters and class labels (columns). 
Health parameters are essentially independ-
ent variables X1i, X2i,…, Xni defining the 
unique characteristics of patients/individuals 
while the class label is a dependent variable 
Yi, Yii,…, Yni) of each sample (Nisbet et al., 
2009) as shown in Table 2.  
Prior to model construction, independent 
variables (quantitative data) are scaled so as 
to afford comparison of variables by means 
of normalization or standardization 
(Nantasenamat et al., 2009, 2010). 
Normalization for independent variables 
is adjusted in the range of 0 and 1 according 
to the following equation: 
  minmax
min
jj
jijnorm
ij xx
xx
x 
   (1) 
where normijx  is the normalized value, ijx  
is the value of interest, minjx  is the minimum 
value and maxjx is the maximum value. 
Standardization for independent variables 
is performed in the mean and unit variance 
by using the following equation: 

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  (2) 
where stnijx  represents the standardized 
value, ijx  represents the value of each sam-
ple, jx  represents the mean of each de-
scriptor, and N  represents the sample size 
of the data set.  
In addition, the original quantitative data 
(without normalization or standardization) 
and qualitative data can also be used to di-
rectly build predictive models. 
In the construction of a predictive model, 
the data set is typically divided into two sets: 
1) training set (i.e. for the training of ma-
chine learning algorithms to recognize pat-
terns and generate models) 2) testing set (i.e. 
for the evaluation of the model). The types 
of generated testing set can be obtained from 
internal and external testing sets. Cross-
validation is an internal testing set which di-
vides the data set into n equal parts whereby 
one part is used as a testing set and the re-
maining parts are used as training sets until 
all parts are used as the testing set. A variety 
of n-fold cross validation selection methods 
have been used to evaluate the predictive 
models such as 10-fold cross-validation used 
for a large number of data set which are gen-
erated into 10 parts, for example, 500 sub-
jects were separated into 10 equal parts, 
where 50 samples were used as the testing 
set and 450 used as the training set. In con-
trast, leave-one-out is employed for data sets 
containing a small number of objects where 
the numbers of folds are equal to the number 
of data sets. Furthermore, model validation 
was also performed using an external set that 
consists of data not used in the model con-
struction (Nantasenamat et al., 2009, 2010).
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Table 2: Typical data set format for data mining 
Data set Descriptor/ 
health  
parameters 1 
Descriptor/ 
health  
parameters 2 
Descriptor/ 
health  
parameters 3 
… Descriptor/ 
health  
parameters n 
Activity/ 
diseases 
(to be  
modeled) 
Sample i X1i X2i X3i … Xni Yi 
Sample ii X1ii X2ii X3ii … Xnii Yii 
Sample iii X1iii X2iii X3iii … Xniii Yiii 
Sample iv X1iv X2iv X3iv … Xniv Yiv 
…    …   
Sample n X1n X2n X3n … Xnn Yn 
X represents descriptors/property/health parameters. 
Y represents activity/property/diseases of interest. 
 
 
The types of machine learning are cate-
gorized into 2 groups: supervised and unsu-
pervised learning. Supervised learning con-
sists of dependent variables assigned as nu-
merical or class labels that make use of ma-
chine learning algorithms for the classifica-
tion or prediction of the data set whereas un-
supervised learning is directly performed on 
the data set for clustering within which de-
pendent variables are not used 
(Nantasenamat et al., 2009, 2010; 
Nantasenamat and Prachayasittikul, 2015: 
Prachayasittikul et al., 2015). Examples of 
data mining techniques used for supervised 
and unsupervised learning are displayed in 
Figure 1. In supervised learning, the data 
mining techniques such as MLR, PLS, ANN 
and SVM are used to construct predictive 
models in outputs of numeric data as classi-
fication and regression models, and DT, AA, 
RF, ANN and SVM are used for generating 
classification model in output of class labels. 
Considering unsupervised learning, the PCA, 
HCA, SOM, kNN clustering and AA, was 
applied for the build-up of clustering or clas-
sifying data in unassigned output data which 
is used for understanding the distribution of 
each cluster and for identifying similar or 
different groups between the information. 
(Nantasenamat et al., 2010; Nantasenamat 
and Prachayasittikul, 2015; Prachayasittikul 
et al., 2015). Each data mining technique has 
shown its advantage and disadvantage such 
as ANN and SVM are non-linear techniques 
as well as black-box methods whereas MLR 
is an easy technique that is limited in a huge 
number of features. Therefore, using data 
mining should be considered with the type of 
data that can interpret significant parameters 
related in the output data. Furthermore, data 
mining could be applied in sciences and 
health from small molecules, chemical pol-
ymer as well as biological macromolecules 
up to the population level (Isarankura-Na-
Ayudhya, 2009).  
 
Data mining for medical/clinical  
applications 
Medical/clinical databases are considered 
as large collections of data composed of pa-
tient/individual information such as patient 
history, physiological and biochemical pa-
rameters and diseases which have been col-
lected in the hospital or laboratory systems. 
Therefore, understanding and revealing rela-
tionships using medical/clinical data are 
needed to obtain new knowledge in medi-
cal/clinical fields. Advances in the realm of 
computational information have allowed the 
development of new methods and tools for 
analyzing large quantities of data. Data min-
ing has made use of medical/clinical data for 
discovering patterns and building predictive 
models (Iavindrasana et al., 2009; Koh and 
Tan, 2005; Lee et al., 2000; Obenshain, 
2004; Ting et al., 2009; Yoo et al., 2012) to 
help physicians in the decision-making for 
diagnosis, prognosis and treatment of pa-
tients. In addition, data mining has been suc-
cessfully applied for identifying and building 
relationship models to display the relation-
ship between health parameters and diseases 
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such as cancer, cerebrovascular disease, dia-
betes mellitus, food-borne diseases, heart 
diseases, hypertension, hyperlipidemia, is-
chemic heart disease, inflammatory bowel 
disease and metabolic syndrome as shown in 
Table 3. 
 
 
Table 3: Example of applications of data mining for medical/clinical data 
Diseases/health 
status 
Description Data mining  
techniques 
References 
Cancer Significant prevention factors 
of cancer were discovered 
using association rule mining 
algorithms. 
AA Nahar et al. (2011) 
Cerebrovascular 
disease 
Data mining was employed 
for constructing predictive 
models for cerebrovascular 
disease and identifying im-
portant influent factors in the 
disease. 
DT, Bayesian clas-
sifier and Back-
propagation neural 
network 
Yeh et al. (2011) 
Diabetes mellitus AA and DT were used to  
analyze diabetes data from 
medical databases.  
AA and DT Quentin-Trautvetter  
et al. (2002) 
 Predictive models of DM 
were constructed using data 
mining techniques (i.e. neu-
ral network, DT and logistic 
regression) as to select rele-
vant factors from anthropo-
metrical body surface scan-
ning data. 
Neural network, DT 
and logistic regres-
sion 
Su et al. (2006) 
Food-borne  
diseases 
Patterns were identified from 
foodborne disease outbreaks 
using data mining tech-
niques. 
AA and DT Thakur et al. (2010) 
Heart diseases Neural network and discrimi-
nant analysis methods were 
utilized for identifying im-
portant risk factors and high 
risk in heart disease patients.
Neural network and 
discriminant analy-
sis 
Lee et al. (2000) 
Hypertension and  
hyperlipidemia 
Different data mining tech-
niques were applied for     
determining common risk 
factors of hypertension and 
hyperlipidemia. 
Logistic regression, 
C5.0 DT, Classifi-
cation and regres-
sion tree (CART), 
CHAID and ex-
haustive CHAID, 
Discriminant analy-
sis and multivariate 
adaptive regres-
sion splines 
Chang et al. (2011) 
Hypertension,  
hyperglycemia and  
hyperlipidemia 
Data mining techniques were 
used to investigate disease 
distribution (i.e. hyperten-
sion, hyperglycemia and hy-
perlipidemia) forms in vari-
ous community resident    
areas to draw up a disease 
distribution map. 
Hierarchical clus-
tering 
Wei et al. (2012) 
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Diseases/health 
status 
Description Data mining  
techniques 
References 
Ischemic heart  
disease 
Back-propagation neural 
network and direct kernel 
SOM was applied to analyze 
magnetocardiography as to 
identify ischemic heart dis-
ease patients. 
Back-propagation 
neural network and 
direct kernel SOM 
Tantimongcolwat et 
al. (2008) 
Inflammatory bowel 
disease 
DT was employed for finding 
relevant factors and deter-
mining low bone mineral 
density in inflammatory bow-
el disease. 
DT Firouzi et al. (2007) 
Metabolic  
syndrome 
SVM and DT were used for 
predicting the MS 
SVM and DT  Karimi-Alavijeh et al. 
(2016) 
Metabolic  
syndrome 
Machine learning methods 
(i.e. DT, ANN, SVM, PCA, 
AA, and RF) were utilized for 
classification of MS and 
identification of significant 
health parameters associat-
ed with MS. 
DT, ANN, SVM, 
PCA, AA and RF 
Worachartcheewan et 
al. (2010b; 2013; 
2015) 
AA: association rule analysis, ANN: artificial neural network, CHAID: Chi-square automatic interaction 
detection, DT: decision tree analysis, PCA: principal component analysis, RF: random forest, SVM: 
support vector machine, SOM: self-organizing map 
 
 
Health parameters 
Health parameters are important varia-
bles for assessing health status and for the 
proper diagnosis of diseases. These parame-
ters are collected in medical databases and 
are obtained when individuals receive their 
health check-up and/or health assessment 
with disease conditions. Generally, a physi-
cian uses blood chemistry and physical ex-
amination together with health history and 
interview in order to evaluate the health sta-
tus of a patient. However, delaying diagnosis 
of diseases may lead to morbidity and mor-
tality for the patient. Therefore, the progres-
sion of informative computational technolo-
gy can help physicians rapidly diagnose and 
find patterns that recognize risk factors relat-
ed to developing diseases. As mention 
above, medical databases collecting a large 
amount of data are interesting and can be 
used as a health status evaluation of diseases 
for individuals. Therefore, to manage this da-
ta, powerful computational tools are neces-
sary. Particularly, machine learning ap-
proaches namely, data mining is applied on 
health parameters as to discover patterns and 
construct predictive models of diseases. The 
benefit of data mining, using biomedical da-
tabases, is for the rapid and automatic diag-
nosis of MS in order to help with therapeutic 
or health prevention for individuals having 
risk factors for disease development. 
 
Statistical analysis 
To evaluate predictive models, the statis-
tical parameters were performed which com-
prised of accuracy, sensitivity, specificity, 
positive predictive value (PPV), negative 
predictive value (NPV) (Kuo et al., 2001) 
and Matthews correlation coefficient (MCC) 
(Matthews, 1975). These statistical parame-
ters are calculated using the following equa-
tions: 
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Accuracy TPTN
(TPTN FPFN)     (3) 
  
Sensitivity TP
(TPFN)       (4) 
 
Specificity TN
(TN FP)     (5) 
 
PPV  TP
(TPFP)       (6) 
NPV  TN
(TN FN)       (7) 
 
MCC  (TPTN) (FPFN)
(TPFP)(TPFN)(TN FP)(TN FN) (8)
   
where TP is the number of true positives, 
TN is the number of true negatives, FP is the 
number of false positives or over-predictions 
and FN is the number of false negatives or 
missed predictions. The value of MCC is 0 
for a random assignment and 1.0 for a per-
fect prediction (Matthews, 1975). 
 
QUANTITATIVE POPULATION-
HEALTH RELATIONSHIP (QPHR) 
The utilization of data mining techniques 
for assessing the health status in a population 
via their health parameters had previously 
been termed by us as quantitative popula-
tion-health relationship (QPHR) 
(Worachartcheewan et al. 2013). QPHR 
makes use of data mining to elucidate the re-
lationship between physical and biochemical 
parameters from populations/patients with 
diseases using data mining technique. 
Data mining has been used to extract and 
explore knowledge from a large amount of 
data in clinical/medicinal settings. A variety 
of data mining techniques including SVM, 
ANN, MLR, PCA, SOM, DT and AA have 
been demonstrated for constructing predic-
tive models of diseases (Chang et al., 2011; 
Firouzi et al., 2007; Kim et al., 2012; Lee et 
al., 2000; Nahar et al., 2011; 
Worachartcheewan et al., 2010a, b, 2013, 
2015; Yeh et al., 2011). In addition, data 
mining has previously been employed to 
generate QSAR/QSPR models for insight in-
to correlations between physicochemical de-
scriptors and their biological/chemical prop-
erties (Nantasenamat et al., 2009, 2010; 
Nantasenamat and Prachayasittikul, 2015; 
Prachayasittikul et al., 2015). 
QPHR models were used to discover un-
known or hidden parameters associated with 
the progression of diseases. The QPHR 
models are performed with a clinical aim in 
diagnosis, prevention and health promotion 
of populations/patients. Furthermore, the 
QPHR models could be useful in medi-
cal/clinical data for identifying important 
risk factors of diseases and classifying indi-
viduals who have risk factors in development 
of said diseases. The procedure of QPHR is 
illustrated in Figure 2. 
The concept of QSAR/QSPR and QPHR 
is similar as they are both used in the con-
struction of predictive models for biologi-
cal/chemical properties (Nantasenamat et al., 
2009, 2010; Nantasenamat and Prachayasit-
tikul, 2015) and diseases (Worachartcheewan 
et al., 2013), respectively. In QSAR/QSPR 
models, quantum chemical and molecular 
descriptors with their bioactivities are used 
to find relationships between physicochemi-
cal properties and their activities while in 
QPHR models, health parameters (physio-
logical and blood chemical testing) with dis-
eases are employed to discover patterns or 
elucidate the relationships between them 
(Table 4). 
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Figure 2: Schematic representation of the QPHR models 
 
Table 4: The concept of QPHR and QSAR/QSPR models 
 POPULATIONS  MOLECULES 
MODEL Quantitative Population-Health 
Relationship (QPHR) 
 Quantitative Structure-Activity/Property  
Relationship (QSAR/QSPR) 
DESCRIPTORS Health parameters such as 
physiological and blood chemis-
try parameters with health sta-
tus 
 Physicochemical properties such as quan-
tum chemical and molecular descriptors 
OUTPUT Disease or non-disease  Biological or chemical properties 
 
The QPHR models could easily be 
adapted for identifying the development of 
other diseases. Therefore, QPHR can be used 
to discover unknown or hidden parameters 
associated with the progression of diseases 
for the diagnosis, prevention and health 
promotion in populations/patients. 
In this review, examples of QPHR inves-
tigations on MS identification were de-
scribed and demonstrated. In addition, Fig-
ure 1 displayed the application of data min-
ing techniques which discovered important 
health parameters as well as risk factors as-
sociated with MS and related diseases to-
gether with the construction of classifica-
tion/prediction models for screening and as-
sessing health status leading to increased the 
well-being in individuals and population 
health.  
MS has been focused as a risk factor as-
sociated with DM and CVD. The main cause 
of MS includes metabolic abnormalities in 
protein, carbohydrate and lipid metabolisms. 
Considering the MS criteria, central obesity 
(BMI/WC), hypertension (SBP or DBP), 
dyslipidemia (TG and HDL-C) and hyper-
glycemia (FPG) are integral component that 
define MS (Table 1). Furthermore, unknown 
components correlating with MS have been 
discovered whereby other factors involved in 
MS such as genes, socioeconomic status, be-
havior and dietary intake were demonstrated. 
In addition, the in-depth components of 
health parameters that occur frequently to-
gether were also illustrated using data min-
ing. Applications of medical data mining for 
the classification of MS is essential for the 
Health status
Health parameters
Data pre-processingMachine learning approaches
Statistical/model evaluation
Metabolic syndrome
Diabetes mellitus
Cardiovascular diseases, etc.
Clinical criteria
Clinical evidence
Family/pateint history
Clinical biochemistry
Anthropometric
Data cleaning
Normalization
Standardization
Feature selection
Decision tree
Artif icial neural network
Support vector machine
Principal component analysis
Association rule analysis
Accuracy
Sensitivity
Specif icity
Positive predictive value
Negative predictive value
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early detection before individuals with high 
risk factors develop DM and CVD. 
 
MS classification using various machine 
learning approaches 
Data mining has been employed to iden-
tify MS using various approaches such as 
ANN, SVM, RT, DT and PCA 
(Worachartcheewan et al., 2013; de Edelenyi 
et al., 2008). In addition, AA technique is al-
so used for discovering combinations of 
metabolic abnormalities of MS that occur 
frequently together. The AA rule is correlat-
ed with the previous studies that involved 
metabolic abnormalities based on high levels 
of TG, FPG and BP and low level of HDL-C 
(Worachartcheewan et al., 2010a, 2010b; 
Lee et al., 2008). Moreover, the term of ap-
plying data mining for assessing health status 
via health parameters has been organized and 
called QPHR by Worachartcheewan et al. 
(2013). QPHR is defined by using health pa-
rameters for the identification associated 
with health status or diseases that can pro-
vide insight into the relationship between an 
individual’s health parameters and the de-
velopment of diseases. In correlating health 
parameters with MS status, several machine 
learning techniques have previously been 
employed, which comprises of ANN, SVM, 
DT and PCA (Worachartcheewan et al., 
2013). Classification models for MS using 
various multivariate analysis have been re-
ported that DT is the best QHPR method 
outperforming ANN and SVM with correct 
classification of MS and non-MS in greater 
than 99 % of cases, followed by ANN and 
SVM displaying an accuracy of more than 
98 % and 91 % (Worachartcheewan et al., 
2013), respectively. PCA is used for cluster-
ing analysis that displays distinctive MS and 
non-MS groups. The AA gave the rules that 
provide health parameters with abnormalities 
of MS component occurring frequently to-
gether (Worachartcheewan et al., 2013). In 
addition, an in-depth analysis for the identi-
fication of MS component combinations 
were explored using AA in order to discover 
metabolic abnormalities of MS components 
occurring frequently together. The AA was 
performed by stratified data from quantita-
tive data to qualitative data using WHO and 
IDF criteria of metabolic abnormalities. This 
finding showed the combinations of MS 
components corresponding to previous stud-
ies and obtained association rules for the def-
inition of MS (Worachartcheewan et al., 
2010b, 2010b; Lee et al., 2008). This work 
was studied in the Thai population.  
Interestingly, DT has been applied to find 
MS components in the urban and rural Kore-
an population (Kim et al., 2012). The MS 
was identified using Modified National Cho-
lesterol Education Program Adult Treatment 
Panel III criteria. DT displayed the combina-
tions of high TG + high SBP, high TG + low 
HDL-C and high WC + high SBP + high 
FPG for MS in the urban population while 
TG + SBP + WC and SBP + WC + FPG for 
MS in the rural population. From this result, 
similar patterns for combinations of MS 
components were observed in the previous 
study and were highlighted by our results 
(Worachartcheewan et al., 2010a, b). 
In addition, DT analysis is considered to 
be a robust data mining technique for con-
structing predictive model of metabolic syn-
drome status with accuracy of 73.90 % (Kim 
et al., 2012) and 99.86 % (Worachartchee-
wan et al., 2010b, 2013). Furthermore, the 
SVM method has been shown to yield accu-
racy of 75.70 % (Karimi-Alavijeh et al., 
2016) and 91.98% (Worachartcheewan et al., 
2013). Moreover, the CHAID decision tree 
has been shown to display an accuracy of 
71.80 % for identifying MS. It was found 
that WC, TG, HDL-C, and FPG were signif-
icant health parameters for the prediction of 
MS (Miller et al., 2014). 
The AA has been used to find patterns of 
MS related diseases. The study conducted on 
Taiwanese population by Chan et al. (2008) 
in MS and DM patients using AA, discov-
ered the relationship between the diseases. It 
was observed that individuals having high 
MS were correlated with liver disease and 
DM individuals were associated with oral 
diseases such as dental carries, pulpitis, acute 
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gingivitis and periodontosis. Thus, the AA 
technique exhibited the rules of relations be-
tween diseases that can be used to help diag-
nosis in order to prevent illnesses in patients. 
Furthermore, this technique was used to 
explore association rules between MS and 
lifestyle (Huang, 2013). It was found that in-
dividuals having a BMI >27 kg/m2 and/or 
participating in vigorous physical exercise 
less than once a week were predisposed to 
having MS. 
In addition, ANN and multiple logistic 
regression have been employed for identify-
ing MS in patients treated with second-
generation antipsychotics (SGAs) (Lin et al., 
2010). The results indicated that ANN and 
logistic regression models gave high accura-
cy of 88.3 and 83.6%, respectively, while 
WC, BMI, DBP and gender were important 
variables for identifying MS in patients un-
dergoing SGA treatment. 
A study conducted on the French popula-
tion by de Edelenyi et al. (2008) showed fac-
tors or combinations of factors associated 
with MS. Particularly, RF was applied for 
predicting the MS status. Dietary and genetic 
parameters were used as independent varia-
bles while MS or non-MS classes were used 
as the dependent variables. Important varia-
bles were deduced from RF including plasma 
concentrations of palmitoleic acid, gamma-
linolenic acid (GLA) and linoleic acid. Fur-
thermore, 3 essential single-nucleotide pol-
ymorphisms (SNPs) were selected by RF 
composed of APOB rs512535, LTA 
rs915654 and ACACB rs4766587. The cor-
rect classification is 71.4% to predict the MS 
status. For interpretation of health parame-
ters, it showed that the palmitoleic acid was 
significantly higher in MS than non-MS 
while APOB rs512535 A>G and ACACB 
rs4766587 A>G correlated with the devel-
opment of MS. Furthermore, the RF method 
was used to explore important health param-
eters and identify MS by Worachartcheewan 
et al. (2015). It was found that TG is consid-
ered as the first significant health parameter 
associated with MS and gave an accuracy 
> 98 % for the classification of MS. These 
results correlated with the previous study 
(Worachartcheewan et al., 2010b). 
The examples of data mining application 
techniques are used for the classification or 
identification of MS. These examples help to 
identify patterns of MS component combina-
tions and find the rules of metabolic abnor-
malities and related diseases associated with 
MS. 
Furthermore, in this review, MS has been 
focused on risk factors associated with DM 
and CVD. MS is associated with metabolic 
abnormalities in protein, carbohydrate and 
lipid metabolisms. Concerning MS criteria, 
central obesity (BMI/WC), BP, dyslipidemia 
(TG and HDL-C) and hyperglycemia (FPG) 
are components that can be used to define 
MS. Furthermore, unknown components cor-
related with MS have been discovered in or-
der to find other factors that are involved 
such as genes, socioeconomic status, behav-
ior and diet. In addition, an in-depth analysis 
of components occurring frequently together 
was demonstrated via data mining. The ap-
plication of medical data mining to classify 
MS is an essential performance for early de-
tection of DM and CVD. Therefore, the data 
mining could be recommended for identifi-
cation of MS during an individual’s health 
assessment. 
A summary of examples employing data 
mining for the classification of MS is pre-
sented in Table 5. It was used to identify pat-
terns or combinations of MS components as 
well as to deduce rules for metabolic abnor-
malities associated with MS. 
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Table 5: Summary of identifying MS using data mining techniques 
SUBJECT HEALTH PARAMETERS HEALTH 
STATUS 
DATA MIN-
ING  
TECHNIQUE 
ACCURACY (%) / 
ASSOCIATED  
FACTORS 
SIGNIFICANT  
VARIABLES  
(RELATED TO MS 
STATUS) 
REFERENCES 
FRANCE WC, FPG, HDL-C, TG, BP, dietary intake, 
genetic (single-nucleotide polymorphism 
(SNPs)) 
MS RF 71.40 Palmitoleic acid of 
16.1, gamma-linolenic 
acid (GLA), linoleic ac-
id, APOB rs512535, 
LTA rs915654 and 
ACACB rs4766587  
de Edelenyi et al. 
(2008) 
IRAN gender, age, weight, BMI, WC, waist-to-hip 
ratio (WHR), hip circumference (HC), phys-
ical activity, smoking history, hypertension, 
antihypertensive medication use, BP, FPG, 
2-hour blood glucose, TG, total cholesterol, 
low-density lipoprotein cholesterol (LDL-C), 
HDL-C, mean corpuscular volume (MCV), 
and mean corpuscular hemoglobin (MCH) 
MS SVM  
DT 
75.70 
73.90 
TG, BMI, BP, FPG 
TG is the most im-
portant feature for pre-
dicting MS 
Karimi-Alavijeh et al. 
(2016) 
KOREA WC, FPG, HDL-C, TG, BP MS DT Identifying urban 
and rural popula-
tion for MS risk 
factors 
TG, SBP, HDL-C, WC 
and FPG in the urban 
population  
TG, SBP, WC and 
FPG in the rural popu-
lation 
TG is the most im-
portant feature for pre-
dicting MS 
Kim et al. (2012) 
TAIWAN WC, FPG, HDL-C, TG, BP, diseases MS, DM AA Finding common 
combination of 
disease related to 
MS and DM status 
MS correlation with 
liver disease and DM 
associated with oral 
diseases 
Chan et al. (2008) 
TAIWAN WC, FPG, HDL-C, TG, BP, lifestyles (i.e. 
shift and type of work, gender, BMI, family 
history, smoking, sleep quality, sleep 
(hrs/day), physical exercise, vigorous phys-
ical exercise (per week), alcohol, fruit intake 
(per week), between-meal snacks (per 
MS AA Finding common 
combination of MS 
components 
BMI, vigorous physical 
exercise, working in 
shifts, gender, coffee, 
family history, alcohol, 
physical exercise, type 
of work, smoking 
Huang (2013) 
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SUBJECT HEALTH PARAMETERS HEALTH 
STATUS 
DATA MIN-
ING  
TECHNIQUE 
ACCURACY (%) / 
ASSOCIATED  
FACTORS 
SIGNIFICANT  
VARIABLES  
(RELATED TO MS 
STATUS) 
REFERENCES 
week), three meals a day (per week), night 
snacks (per week), soft drinks with sugar 
(per week), coffee (per week), tea (per 
week) 
TAIWAN demography (i.e. age, gender), anthropom-
etry (i.e. BMI, BP, WC), blood chemistry 
(i.e. TG, FPG, HDL-C), medications (i.e. 
SGA agent, duration of using SGA, mood 
stabilizer, hypertension medication, com-
bined antipsychotic) 
MS ANN 
Logistic     
regression 
88.30 
83.60 
gender, WC, BMI, 
DBP  
Lin et al. (2010) 
THAILAND demography (i.e. age, gender), anthropom-
etry (i.e. BMI, BP), blood chemistry (i.e. 
FPG, blood urea nitrogen, creatinine, uric 
acid, cholesterol, TG, HDL-C, LDL-C, as-
partate aminotransferase, alanine ami-
notransferase, alkaline phosphatase, he-
moglobin, hematocrit, white blood cell count 
and platelet count) 
MS ANN 
SVM 
RF 
DT 
PCA 
AA 
98.78 
91.98 
98.11 
99.86 
Clustering 
Finding common 
combination of MS 
components 
gender, TG, SBP, 
DBP, FPG and HDL-C 
TG is the most im-
portant feature for pre-
dicting MS 
Worachartcheewan 
et al. (2010b, 2013, 
2015) 
UNITED 
STATES 
demography (i.e. age, gender). anthropo-
metric (i.e., weight (kg), height (cm), BMI, 
BP, and WC). blood chemistry (i.e. HDL-C, 
TG, FPG) 
MS CHAID deci-
sion 
trees  
71.80 WC, TG, HDL-C, and 
FPG 
WC is the most im-
portant feature for pre-
dicting MS 
Miller et al. (2014) 
 
AA: association rule analysis, ANN: artificial neural network, CHAID: Chi-square automatic interaction detection, DT: decision tree analysis, MS: metabolic 
syndrome, PCA: principal component analysis, RF: random forest, SGAs: second-generation antipsychotics and SVM: support vector machine 
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CONCLUSION 
This review article represents the first 
work of its kind whereby a summary of data 
mining for the assessment of MS status and 
discovery of in-depth MS components has 
been portrayed. This article summarizes the 
utilization of data mining techniques as a 
rapid identification tool for the classification 
of MS and non-MS categories. Complemen-
tary knowledge gained from association 
analysis provides pertinent information on 
frequently occurring parameters for defining 
MS. Furthermore, decision tree analysis of-
fers insights on rules leading up to MS or 
non-MS groups. The topics covered in this 
article represent an exciting and growing ar-
ea whereby various machine learning tech-
niques offer useful insights in unravelling the 
mechanistic basis for MS. 
The applications of data mining for the 
identification of MS and non-MS have been 
demonstrated and could potentially be em-
ployed as a rapid identification tool for clas-
sifying MS. Furthermore, association rule 
analysis was able to discover the important 
rules for defining MS. In addition, DT has 
been shown to be a robust machine learning 
approach for classifying MS and therefore 
holds great potential for assessing an indi-
vidual’s risk of MS. 
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